Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cidofovir for Peripheral CMV Retinitis in AIDS
NCT00002437Phase 2Completed
- Sponsor
- Gilead Sciences
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of cidofovir in cytomegalovirus retinitis, sponsored by Gilead Sciences. Status: completed.
02
Drugs
cidofovir
03
Conditions
cytomegalovirus retinitis
Beyond the preview
Go deeper on NCT00002437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002437.